T1	Participants 219 243	hemodialysis population.
T2	Participants 419 427	Patients
T3	Participants 548 569	AVF creation patients
T4	Participants 740 788	Twenty-seven patients participated in the study.
T5	Participants 1227 1258	patients with BB and PTFE AVFs.
